Rare diseases
Investigational molecules
Locations
Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack
SwedenStudy of AZD3427 for Patients with Heart Failure and Pulmonary Hypertension from Left Heart Disease
SwedenStudy of Pembrolizumab, Vibostolimab, and Favezelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Unresponsive to BCG Therapy
SwedenStudy on JNJ-81201887 for Treating Geographic Atrophy in Age-related Macular Degeneration Patients
SwedenStudy on the Effectiveness and Safety of Bemnifosbuvir for High-Risk COVID-19 Patients
SwedenStudy of Navtemadlin as Maintenance Therapy for Patients with Advanced or Recurrent Endometrial Cancer After Chemotherapy
SwedenStudy on the Effectiveness and Safety of Ulotaront for Adults with Generalized Anxiety Disorder
SwedenStudy Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Stage II-IV Melanoma
SwedenStudy Comparing Darolutamide and Androgen Deprivation Therapy to Placebo and Androgen Deprivation Therapy in Men with High-Risk Prostate Cancer Recurrence
SwedenStudy on Luspatercept and Epoetin Alfa for Treating Anemia in Patients with Low to Intermediate Risk Myelodysplastic Syndromes Needing Blood Transfusions
SwedenStudy on Reduced BCG Dwell-Time for Patients with High-Risk Urothelial Cancer
SwedenStudy Comparing MK-4280A (Favezelimab and Pembrolizumab) with Chemotherapy for Patients with Relapsed or Refractory Classical Hodgkin Lymphoma
SwedenTell us about your condition – we search every trial in Europe and connect you with the right site.
